Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Betsy Williams

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Advances in Therapy|February 7, 2026
Measuring What Matters to Patients with Pompe Disease: A Review of Clinical Outcome Assessments for Capturing Treatment Benefits of Innovative Novel TherapiesDiana Rofail, France Ginchereau Sowell, Betsy Williams, et al.
Epilepsy Research|January 25, 2015
Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trialsIlo E Leppik, Robert T Wechsler, Betsy Williams, et al.
Rheumatology (Oxford, England)|March 11, 2022
Causal cascade of direct and indirect effects of anifrolumab on patient-reported outcomes: structural equation modelling of two Phase 3 trialsDonald Stull, Sean O'Quinn, Betsy Williams, et al.
Seizure|March 12, 2017
Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical dataSanjeev Kothare, Gerhard Kluger, Rajesh Sachdeo, et al.
Advances in Therapy|January 27, 2026
Development of a Novel Patient-Reported Outcome Diary to Capture and Monitor Home-Managed Pain Crises in Patients with Sickle Cell DiseaseJames Turnbull, Betsy Williams, Shane Myrick, et al.
Neurology and Therapy|May 11, 2025
Advancing Future Amyotrophic Lateral Sclerosis Medicines by Incorporating The Patient Voice Into Patient-Centered Holistic Measurement Strategies for Clinical and Real-World Studies: Results from Targeted Literature ReviewsDiana Rofail, Michael Chladek, Betsy Williams, et al.
Disability and Rehabilitation. Assistive Technology|November 11, 2020
Motivate-to-move: development of an intervention promoting parental adherence to early power mobility programsLisa K Kenyon, Victoria M Krajenka, Katie Lach, et al.
Epilepsia|July 4, 2015
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanelAlan B Ettinger, Antonia LoPresti, Haichen Yang, et al.
Journal of the American Society for Mass Spectrometry|June 1, 2005
Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometryAnna C Crecelius, D Shannon Cornett, Richard M Caprioli, et al.
Epilepsy Research|May 22, 2021
A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanelGregory L Krauss, Elinor Ben-Menachem, Robert T Wechsler, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Advances in Therapy|February 7, 2026
Measuring What Matters to Patients with Pompe Disease: A Review of Clinical Outcome Assessments for Capturing Treatment Benefits of Innovative Novel TherapiesDiana Rofail, France Ginchereau Sowell, Betsy Williams, et al.
Epilepsy Research|January 25, 2015
Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trialsIlo E Leppik, Robert T Wechsler, Betsy Williams, et al.
Rheumatology (Oxford, England)|March 11, 2022
Causal cascade of direct and indirect effects of anifrolumab on patient-reported outcomes: structural equation modelling of two Phase 3 trialsDonald Stull, Sean O'Quinn, Betsy Williams, et al.
Seizure|March 12, 2017
Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical dataSanjeev Kothare, Gerhard Kluger, Rajesh Sachdeo, et al.
Advances in Therapy|January 27, 2026
Development of a Novel Patient-Reported Outcome Diary to Capture and Monitor Home-Managed Pain Crises in Patients with Sickle Cell DiseaseJames Turnbull, Betsy Williams, Shane Myrick, et al.
Neurology and Therapy|May 11, 2025
Advancing Future Amyotrophic Lateral Sclerosis Medicines by Incorporating The Patient Voice Into Patient-Centered Holistic Measurement Strategies for Clinical and Real-World Studies: Results from Targeted Literature ReviewsDiana Rofail, Michael Chladek, Betsy Williams, et al.
Disability and Rehabilitation. Assistive Technology|November 11, 2020
Motivate-to-move: development of an intervention promoting parental adherence to early power mobility programsLisa K Kenyon, Victoria M Krajenka, Katie Lach, et al.
Epilepsia|July 4, 2015
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanelAlan B Ettinger, Antonia LoPresti, Haichen Yang, et al.
Journal of the American Society for Mass Spectrometry|June 1, 2005
Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometryAnna C Crecelius, D Shannon Cornett, Richard M Caprioli, et al.
Epilepsy Research|May 22, 2021
A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanelGregory L Krauss, Elinor Ben-Menachem, Robert T Wechsler, et al.
Pageof 5